Summary The development of antioestrogen resistance is a major clinical obstacle encountered in the treatment of breast cancer. By long-term growth in oestrogen-free medium, we have derived an oestrogenindependent, anti-oestrogen resistant cell line from the oestrogen receptor (ER)-positive, oestrogen-dependent T47D human breast cancer cell line. This cell line grows maximally in oestrogen-free medium and is resistant to all tested antioestrogens. This cell line does not express any measurable amounts of ER mRNA or protein and, in short-term studies, these cells show no response to either oestrogens or antioestrogens. However, return of these cells to oestrogen-containing medium for more than 8 weeks resulted in the re-expression of ER mRNA and protein. Subsequent limiting dilution subcloning of the T47D:C4 line revealed two phenotypically distinct clones, one which did not express measurable ER after long-term growth in oestrogen-containing medium and one which expressed ER mRNA and protein after a number of weeks in oestrogen-containing medium. In the absence of oestrogen, both types of cells are ER-negative as determined by Northern and Western blotting and lack of any oestrogen-dependent responses. The clone which re-expresses the ER (T47D:C4:5W) now responds to E2 with a 50% increase in growth and a 30-fold induction of an ER-reponsive luciferase reporter construct. Long-term growth of the stably ER-negative clone (T47D:C4:2W) causes no measurable oestrogen-mediated responses, as assessed by ER expression, growth stimulation or luciferase induction. Interestingly, ER mRNA can be detected in both cell types by using reverse transcriptase-polymerase chain reaction (RT-PCR). This suggests that the ER mRNA present in the T47D:C4:2W clone is either inefficiently translated or is present at such a low level as to be functionally irrelevant. These novel clonal cell lines will prove to be invaluable in the study of the regulation of ER expression and regulatory pathways leading to oestrogen-independent growth.
The hormonal dependence of breast cancer has been known since the studies of Beatson in the late nineteenth and Boyd in the early twentieth century (Beatson, 1896; Boyd, 1900) . In these studies ovariectomy was shown to inhibit the growth of advanced breast cancers. The development of in vitro breast cancer models was pioneered by Soule (Brooks et al., 1973; Soule et al., 1973) , but the finding that the cells would respond to oestrogens and antioestrogens by Lippman (1976) allowed the investigation of oestrogenic growth stimulation in this particular target tissue.
The clinical response of human breast cancer to endocrine therapy is dependent upon a functional oestrogen receptor (ER) . At diagnosis nearly 70% of all primary breast cancers express measurable levels of the ER and, of these, 50% also express progesterone receptor (PR) (Paridaens, 1995) . The expression of PR has been shown to be dependent upon an activated ER complex and, therefore, PR expression is used as a measure of the activity of the ER present in these tumours. It has been shown that the use of ER and PR expression is invaluable as a prognostic indicator for antioestrogen response (Clark et al., 1984) . Tumours with neither ER nor PR show less than a 10% response to any hormonal manipulation, including the non-steroidal antioestrogen tamoxifen, which is currently the hormonal treatment of choice for breast cancer (Jordan, 1994) . However, nearly 80% of tumours expressing ER and PR will show an objective response to hormonal manipulation. Unfortunately, following an initial response, nearly all advanced breast cancers will develop resistance to this treatment. The changes that allow these resistant cells to develop and eventually lead to disease progression are multifaceted and largely unknown. Loss of oestrogen dependence is not always a precursor to the development of antioestrogen resistance. However, these two characteristics are theorectically and observationally linked. The expression of ER in tumours as they progress has recently been reviewed by Robertson (1996) . In this review, the loss of ER expression in previously ER-positive tumours is seriously questioned. The hypothesis that ER expression is stable in breast cancer has significant consequences in the treatment of breast cancer. Many laboratories (Brunner et al., 1993; Clarke et al., 1989; Dickson and Lippman, 1986; Katzenellenbogen et al., 1987; Wilding et al., 1988) including our own (Jiang et al., 1992; Murphy et al., 1989; Pink et al., 1995; Robinson and Jordan, 1989; Welshons and Jordan, 1987) have used cell culture models of human breast cancer to study the development of oetrogen independence and antioestrogen resistance.
The discovery of the oestrogenic activity of the pH indicator, phenol red, and its removal from tissue culture medium (Berthois et al., 1986) , allowed us, as well as other laboratories, to analyse the changes in breast cancer growth in long-and short-term oestrogen deprivation studies. Previously, we described two clones derived from the MCF-7 human breast cancer cell line, which were selected in oestrogen-free medium. Both of these clones grow maximally in oestrogen-free medium and continue to express the ER. One clone, MCF-7:5C, is oestrogen and antioestrogen resistant in all measured responses (Jiang et al., 1992) . The growth of the other clone, MCF-7:2A, is also oestrogen independent, but can be dramatically inhibited by antioestrogens. This cell line also expresses a unique 80 kilodalton (kDa) ER which contains an in-frame duplication of exons 6 and 7 (Pink et al., 1995 .
In parallel studies we examined the development of oestrogen independence in the T47D cell line (Murphy et al., 1989 (Murphy et al., , 1990 . This cell line has been well studied in numerous laboratories throughout the world. The initial characterisation of this cell line established that it was ER and PR positive and required oestrogen for maximal growth (Chalbos et al., 1982; Keydar et al., 1979) . Interestingly, independently maintained clones used in various laboratories now show a diversity of phenotypes (Fernandez et al., 1994; Graham et al., 1990; Horwitz and Freidenberg, 1985; Karey and Sirbasku, 1988; Mullick and Chambon, 1990; Murphy et al., 1989; Nardulli and Katzenellenbogen, 1988; Reese et al., 1988; Wang and Miksicek, 1991) .
In studies described here we investigate the characteristic of two T47D clones, which have lost their oestrogen responsiveness following growth in oestrogen-depleted medium. These clones and the parental oestrogen-responsive cell line, T47D:A18, will be excellent models in which to investigate the changes associated with the development of oestrogen independence and the subsequent re-expression of the ER in human breast cancer.
Materials and methods
Tissue culture T47D cells were originally obtained from the American Type Culture Collection (ATCC), Rockville, MD, USA). All tissue culture components were purchased from Gibco Laboratoriers, Grand Island, NY, USA, unless otherwise stated. Cells were grown in RPMI-1640 supplemented with 10% fetal bovine serum (FBS; Bioproducts for Science Inc., Indianapolis, IN, USA), 6 ng ml-' bovine insulin, 25 mM Hepes, 2 mM L-glutamine, 100 U ml-' penicillin, 100 ,ug ml-1 streptomycin and 250 ng ml-' amphotericin B (fully oestrogenised medium). Oestrogen-free medium substitutes phenolred free RPMI-1640 and 3 x dextran-coated charcoal-treated FBS in the above. Cells were routinely passed at 1: 5-1: 20 dilutions once per week using 0.1% trypsin. All cells were grown in a 37°C humidified incubator with 5% carbon dioxide. Derivation of the T47D:A18 and T47D:C4 lines has been described previously (Murphy et al., 1989 (Murphy et al., , 1990 Western blotting Western blotting was performed as described previously and RLU was then reported. All points were corrected for transfection efficiency by dividing RLU by /3-galactosidase activity. /3-Galactosidase activity was measured using a MUG assay (Luyten et al., 1985) . Briefly, an aliquot of the cell is mixed with 1.3 ml reaction buffer containing 0.1 M sodium phosphate, 10 mM potassim chloride, 1 mM magnesium sulphate, pH 7.0 and 2.2 (10-5)g ml-'1B-methyllumbelliferone (MUG) (Molecular Probes Inc., Eugene, OR, USA). The sample is incubated at room temperature for 1 h and 750 Ml of stop buffer (15 mM EDTA, 0.3 M glycine, pH 11.2) is added. The samplcs are then read in an LS-5 fluorescence spectrophotometer (Perkin Elmer, Foster City, CA, USA) with excitation at 350 nm and absorption at 450 nm. All Oestrogen receptor expression in T47D cell lines JJ Pink et al samples are correlated to a standard curve using purified f,-galactosidase (Boehringer Mannheim Biochemicals, Indianapolis, IN, USA).
Northern and RNA dot-blot analysis RNA was isolated from two 100 cm2 dishes using a procedure of direct poly A RNA purification (Badley et al., 1988) . Briefly, the cells were washed twice in ice-cold PBS containing 50 gM ATA and then lysed in a solution of 0.2 M sodium chloride, 0.2 M Tris-HCl, pH 7.5, 1.5 mM magnesium chloride, 2% SDS, 200 Mg ml-' proteinase K and 50 pM aurin tricarboxylic acid (ATA). Following shearing of the DNA through a 22 g needle five times, the lysate is mixed with oligo-dT cellulose for 2 h at room temperature. The oligo-dT pellet is then washed four times with binding buffer (0.5 M sodium chloride, 0.01 M Tris-HCl, pH 7.5) by spinning at 500 x g in a Beckman J6-B centrifuge at room temperature. The RNA is eluted in five batches by resuspending the oligo-dT pellet in elution buffer (0.01 M Tris-HCl, pH 7.5) and spinning at top speed in a microfuge for 30 s. The RNA was denatured by heating to 65°C for 15 min in 10 mM MOPS, pH 7.0, 4 mM sodium acetate, 0.5 mM EDTA, 6.5% formaldehyde and 50% deionised formamide. For Northern blots the denatured RNA was loaded onto a 1.2% agarose/formaldehyde gel and run overnight at 25V with buffer recirculation. Transfer was performed using a Vacu-Gene transfer apparatus (Pharmacia Biotech Inc., Piscataway, NJ, USA) according to the manufacturer's directions. For dot-blots the dilutions were then spotted onto Hybond-N (Amersham) using a Hybri-Dot manifold (BRL, Gaithersburg, MD, USA), 0.5-20 Mg RNA per well and each well was rinsed under low vacuum once with 400 Ml 10 x saline sodium citrate (SSC). The membranes for both dot-blots and Northern blots were then UV fixed using a UV Stratalinker 2400 (Stratagene, La Jolla, CA, USA) and air dried before prehybridisation. Prehybridisation was performed at 45°C using a solution comprised of 5 x SSC, 20 mm sodium phosphate, pH 6.5, 0.6% polyvinylpyrrolidone, 0.1% Ficoll, 0.1% BSA, 0.2% SDS, 250 Mg ml-' denatured salmon sperm DNA, 50% deionised formamide and 10% sodium dextran sulphate. The DNA probes were prepared by random primer labelling using Klenow polymerase (Promega, Madison, WI, USA). Hybridisation was carried out by adding 2-4 x 107 d.p.m. ml-' of the denatured probes directly to the prehybridisation buffer and incubating for 12-16 h at 45°C. The membranes were then washed in 2 x SSC, 0.2% SDS at room temperature for 2-3 h with four buffer changes, followed by one wash in 0.1 x SSC, 0.2% SDS at 65°C for 15 min. The membranes were then exposed to Kodak X-OMAT film in an autoradiography cassette containing double Quanta III intensifying screens at -700C for 24-200 h. The cDNA was amplified in five separate overlapping regions as previously described (Wolf and Jordan, 1994) and shown in Figure 9b . After amplification the resultant 32p_ labelled DNA underwent restriction enzyme digest with the enzyme appropriate for each primer pair. After To study the time frame of the ER-re-expression, T47D:C4 cells were cultured in oestrogen-containing medium and RNA was prepared periodically. These RNA samples were probed for ER expression using the human ER cDNA in a dot-blot. A parallel group was cultured in oestrogen-containing medium plus 100 nM 4-hydroxytamoxifen (4-OHT) in order to examine the effect of antioestrogens on the ER mRNA reexpression. In the dot-blot shown in Figure 2 , it can be seen that the ER mRNA becomes visibly expressed after approximately 5 weeks and is nearly equal to that of the T47D:A18 cells by 9 weeks. The presence of 4-OHT can completely block this re-expression, even after 18 weeks in oestrogen-containing medium. This clearly demonstrates the involvement of the ER in this process. PR expression was also measured in these samples and was shown to mirror the ER expression (data not shown).
To determine if this response was caused by a global reexpression of the ER, as opposed to the selective outgrowth of an ER-positive subpopulation, the T47D:C4 cells were subjected to another round of limiting dilution subcloning in oestrogen-free medium. Nine clones were chosen for further study and each clone was divided into two groups; one was cultured in oestrogen-free medium and the other was switched to medium containing whole serum and phenol red. After 6 weeks of culture, mRNA was prepared and analysed in Northern blot using the human ER cDNA. T47D:C4 cells were cultured in oestrogen-containing medium at time 0 and RNA was prepared at various intervals. RNA dilutions were then loaded into a dot-blot at the amounts noted at the top of the blot (jg per well). The T47D:C4 cells were also cultured in complete medium containing 10-7M 4-OHT and RNA was prepared at 18 weeks. This dot-blot was then hybridised with the 32P-labelled human ER cDNA. Figure 3 clearly shows that the T47D:C4 cells contain two distinct subpopulations. The majority of the clones do not express ER mRNA after 6 weeks in oestrogen-containing medium. However, two clones T47D:C4:4 and T47D:C4:5, showed measurable ER mRNA after 6 weeks in oestrogencontaining medium. The designation 'W' at the end of a clone name indicates that these cells are routinely cultured in oestrogen-containing medium with whole serum. Loading and transfer efficiency was determined by reprobing the blot with a human f3-actin cDNA probe. The culture history of these various clones is illustrated in Figure 4 . One ER-positive and one ER-negative clone were chosen for further study. The clone, T47D:C4:2W, was selected as a permanently ERnegative clone and the T47D:C4:5W clone was selected to represent the originally ER-negative clone, which could reexpress the ER when cultured in oestrogen-containing medium. The T47D:A18 clone was included in all studies as an ERpositive oestrogen-dependent control.
ER protein expression A number of studies were then undertaken in order to assess the expression and activity of the ER in the clones. The expression of the ER protein was measured in a Western blot using the monoclonal antibody H222. All cell lines were continuously cultured in medium containing whole serum and phenol red in order to ensure that the T47D:C4:2W clone was truly ER negative and would remain ER negative even when grown in oestrogen-containing medium for prolonged times. Before studying the effect of oestrogen on the cells, they were grown in oestrogen-free medium for 4-6 days. Figure 5 shows the result of a Western blot of whole cell extracts of the clones following growth in oestrogen-free (-) or oestrogen-containing medium (+) for 6 days. Both the T47D:A18 and T47D:C4:5W clones express measurable ER protein, which is decreased in the T47D:A18 cells following growth in oestrogen-deprived medium. The T47D:C4:2W cells, in contrast, do not express any measurable ER in either culture medium.
Growth response
The consequence of re-expression of the ER was then assessed in a 6 day growth assay. Dose-reponse curves were generated by measuring growth of the T47D:A18, T47D:C4:2W and T47D:C4:5W cells in the presence of varying concentrations of E2 and/or 4-OHT ( Figure 6 ). The growth of the T47D:A18 cells in oestrogen-containing medium is 6-fold higher than that of T47D:A1 8 cells grown in the absence of oestrogen (Figure 6a) . Growth of the T47D:A18 clone in the presence of 4-OHT alone showed a partial oestrogenic effect (approximately 50% growth increase) (Figure 6b ) and the addition of 4-OHT could inhibit the E2-stimulated growth of the T47D:A18 clone (Figure 6c ). The ER-negative T47D:C4:2W clone displays no change in growth in any treatment group. The T47D:C4:5W clone exhibits an intermediate phenotype with a higher basal growth rate in control medium and an approximately 2-fold increase in growth in the presence of E2. The addition of 4-OHT was able to inhibit this growth stimulation (Figure 6c ). Treatment with 4-OHT alone had no effect on the T47D:C4:5W cells until concentrations greater than 10-6 M were achieved. At these higher concentrations of 4-OHT, a non-ER-mediated toxicity is observed, as demonstrated by the growth inhibition seen in all the cells, including the T47D:C4:2W clone.
Reporter gene induction The function of the ER was further assessed by testing the ability of the clones to induce expression of a luciferase reporter construct under the control of three copies of the consensus vitellogenin A2 oestrogen response element. As seen in Figure 7 , the T47D:A18 clohe gives a dramatic (>100-fold) dose-dependent induction of luciferase in the presence of E2. 
Southern blotting
The genomic structure of the ER in the clones was then investigated using standard Southern blotting techniques. EcoRI-and HindIII-digested genomic DNA was used to assess any changes in the restriction pattern of the ER gene in the three clones. As seen in Figure 8 , the pattern of restriction fragments is unchanged in the three clones. These data indicate that the E2-independent clones have not lost the ER gene or undergone any major structural alterations of the gene.
SSCP analysis
Lastly, the structure of the ER mRNA in the clones was analysed using oligo-dT (12 18 region of the ER cDNA, were used to amplify sections of the cDNA (Figure 9b) . These products were then run on a nondenaturing SSCP gel. Shown in Figure 9a are the results from this analysis. MCF-7:WS8 cDNA was included as a wild-type ER-positive control and MDA-MB-231 cDNA was included as an ER-negative control (Pink et al., 1995) . Surprisingly, all groups, except the water control, gave rise to PCR products in all primer sets. 
Discussion
The development of oestrogen-independent growth in previously oestrogen-dependent breast cancers is a major obstacle in the hormonal treatment of these tumours. Expression of the ER is absolutely critical for the maintenance of oestrogen dependence and, while the presence of functional ER does not always correlate with oestrogen-responsive growth, its complete absence always correlates with a loss of oestrogen responsiveness. The clinical relevance of the loss of the ER has recently come into question as, described by Robertson (1996) . This phenomenon is currently under intense investigation in the context of the use of the new pure antioestrogens, which have been shown to function by causing a rapid loss of the ER (Gibson et al., 1991; . In order to investigate the mechanisms responsible for the loss of E2 dependence and ER expression, we have developed and studied clones of the T47D human breast cancer cell line with various responses to oestrogens and antioestrogens. These clones were originally derived simply by selecting cells that could grow in oestrogenfree medium. The original cell population, T47D:C4, was subsequently shown to be comprised of at least two distinct subpopulations.
One group, exemplified by the T47D:C4:2W clone, has permanently lost its ability to express ER and PR and no longer responds to either oestrogens or antioestrogens. Previous reports have described T47D cells with altered hormone responsiveness, including the T47Dco cells, which express low levels of ER and constitutively express PR (Horwitz et al., 1982) . The T47Dco cells have also been shown to express mutant ER mRNAs. However, while these RNAs code for proteins with altered activities, as assessed in heterlogous systems, the mutant proteins have not been detected in the T47Dco cells (Leslie et al., 1992) . Subse- Log molar oestradiol concentration Figure 7 Activation of a luciferase reporter construct in T47D clones. Cells were grown in oestrogen-free medium for 2 days before being plated at 500 000 cells per well in 6-well tissue culture plates. T47D:A18 (-E1-), T47D:C4:2W (-A-) quently, other T47D clones have been described, which no longer express measurable PR following selection by flow cytometric sorting. However, the ER status of these T47D-Y cells has not been reported (Sartorius et al., 1994) . The permanent loss of both ER and PR expression and development of complete oestrogen and antioestrogen sensitivity in vitro is a unique development and has not been reported previously. In conjunction with the oestrogenresponsive parental T47D:A18 clone, these cells will be a unique model in which to study the specific changes responsible for the loss of oestrogen-dependent growth. Previous studies have used E2 responsive and non-responsive cell lines with no common link other than their being originally derived from breast cancers. The fact that the T47D:A18 and T47D:C4:2W clone both come from a common progenitor, as proven by DNA fingerprinting analysis (Murphy et al., 1990) , should allow the use of techniques, such as differential display (Chen and Sager, 1995) and representational difference analysis (Lisitsyn et al., 1993) , to isolate gene products, which are either overexpressed or repressed with the development of oestrogen independence. The background differences inherent when using cells from different sources will be eliminated in this model system.
The expression of ER mRNA in the T47D:C4:2W clone, as measured by PCR, is a provocative finding, but this amount of ER mRNA appears to be functionally insignificant. Using a variety of PCR conditions, we have consistently observed specific ER PCR products in the T47D:C4:2W and MDA-MB-23 1 cells at levels estimated between 25% and 50% that observed in the T47D:A18 and MCF-7 cells. (Ferguson et al., 1995) .
The regulation of ER expression in T47D cells is quite different from that observed in MCF-7 cells and the development of oestrogen-independent clones in these cell lines mirrors these differences . The oestrogen-independent clones that have been isolated from MCF-7 cells, display a different phenotype from that observed for the T47D clones. In short-term studies, MCF-7 cells show increased expression of ER mRNA and protein following removal of oestrogens and this increase can be reversed by addition of oetrogens. However, MCF-7 cells, which have adapted to growth in oestrogen-free medium for more than 3 months, show a consistent but unusual phenotype. They express high levels of ER and their growth is inhibited by antioestrogens, but oestrogens cannot increase their growth above basal levels. The addition of oestrogens to the culture medium also causes an increase in PR mRNA and protein, suggesting that the ER in these cells is still functional (Katzenellenbogen et al., 1987; Welshons and Jordan, 1987) . We have previously isolated and characterised two oestrogenindependent subclones in long-term studies. The MCF-7:5C clone expresses wild-type ER but is completely oestrogen independent and antioestrogen resistant (Jiang et al., 1992 an oestrogen-responsive reporter plasmid in transient transfection studies. Like growth, the basal luciferase activity, mediated through the ER can be inhibited by antioestrogens (Pink et al., 1995 Our studies on the effects of oestrogen withdrawal on the T47D cell lines are especially relevant in the light of the current clinical studies with the pure antioestrogen, ICI 182,780 (DeFriend et al., 1994; Howell et al., 1995) .
Previously, the evaluation of ER expression in clinical samples following the development of tamoxifen resistance revealed a predominantly ER-positive population (Encarnacion et al., 1993) . This is in contrast to the laboratory and clinical observations following ICI 182,780 treatment, whereby ER levels drop almost universally to undetectable levels (DeFriend et al., 1994; Gibson et al., 1991) . Mechanistically, this would be analogous to complete oestrogen withdrawal, which previously could not be achieved clinically. If the clinical response to complete oestrogen withdrawal is similar to that observed in the T47D clones described here, we would hypothesise that the pure antioestrogens may give rise to a higher proportion of ER-negative, completely hormonally insensitive tumours. This is in contrast to MCF-7 tumours, which show a different regulation of ER expression . MCF-7 cells show an increase in ER expression following oestrogen deprivation. Depending upon the type of regulation that is present in the individual tumour observed clinically, the response to pure antioestrogen treatment may vary dramatically. Our data suggest that T47D-like tumours may show a rapid development of oestrogen-independent growth. Treatment of these tumours with a second-line antioestrogen would be futile. In contrast, tumours that have become resistant to tamoxifen therapy have been shown to respond to a second-line treatment with ICI 182,780 (Howell et al., 1995; Osborne et al., 1995) . This suggests that the most efficacious treatment scheme would employ tamoxifen initially, followed by the use of ICI 182,780 after disease recurrence. 
